About

IMPACT (IMProving and ACcelerating Translation) Grants support projects focused on one or more of the following key issues contributing to the lack of translation of effective treatments through to clinical trial for MND/ALS: 

  1. Disease heterogeneity 
  2. Lack of relevant preclinical models 
  3. A lack of reliable disease biomarkers 
  4. The challenge of drug delivery into the brain 
  5. A lack of effective targeted gene therapies 
  6. The untapped potential of stem cell therapy 

These grants are for support of 2-year projects up to the value of AUD $300,000. Applications MUST address one of the 6 key areas to be considered. 

Applicants MUST address one of the six key issues to be considered. 

Eligibility and how to apply 

FightMND invites applications for research based in institutions worldwide. Investigators at all academic levels are eligible to submit applications. 

Applications for IMPACT grants must be submitted through FightMND’s online grants management system, Fluxx.

Application Limits

Applicants are limited to THREE (3) applications per person in total as an investigator (Primary or Co-Investigator) across all research schemes (excluding Fellowships).  There is no restriction on grants as a collaborator  

Minimum data requirement

FightMND are introducing a minimum data requirement for all schemes that do not have a Letter of Intent stage (IMPACT, Discovery, Early and Mid Career Fellowships).  

Primary Investigators MUST complete minimum data requirements by 23rd Feb 2026 5pm AEDT. After this time, the form will close and applications cannot be commenced in the Fluxx system. Minimum data MUST be completed for your application to be considered in 2026. 

Fields required are: 

  • Primary Investigator name 
  • Primary Investigator Affiliation 
  • Co-Investigators names (optional) 
  • Project title 
  • Keywords x4 
  • IMPACT priority area  

The following documents will assist with your application: 

Videos to guide your submission using the FightMND Grant Management System – Fluxx: